Document Detail

Role of vitamin D in arterial hypertension.
MedLine Citation:
PMID:  21090935     Owner:  NLM     Status:  In-Process    
Vitamin D deficiency is highly prevalent and may contribute to arterial hypertension. The antihypertensive effects of vitamin D include suppression of renin and parathyroid hormone levels and renoprotective, anti-inflammatory and vasculoprotective properties. Low 25-hydroxyvitamin D levels, which are used to classify the vitamin D status, are an independent risk factor for incident arterial hypertension. Meta-analyses of randomized controlled trials showed that vitamin D supplementation reduces systolic blood pressure by 2-6 mmHg. However, further studies are needed before drawing a final conclusion on the effect of vitamin D therapy on blood pressure and cardiovascular risk. In our current clinical practice we should take into account the high prevalence of vitamin D deficiency, the easy, cheap and safe way by which it can be supplemented and the promising clinical data suggesting that vitamin D might be useful for the treatment of arterial hypertension as well as other chronic diseases. Therefore, we recommend that testing for and treating vitamin D deficiency in patients with arterial hypertension should be seriously considered.
Stefan Pilz; Andreas Tomaschitz
Related Documents :
19961945 - Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.
16365195 - Electrocardiographic strain pattern and prediction of new-onset congestive heart failur...
2294515 - Type a behavior and cardiovascular responses during verbalization in cardiac patients.
16222605 - Mechanisms of vascular disease in hypertension with special reference to diabetes.
20217135 - Temporal alterations in cardiac fibroblast function following induction of pressure ove...
19392925 - Valsartan vs. other angiotensin ii receptor blockers in the treatment of hypertension: ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Expert review of cardiovascular therapy     Volume:  8     ISSN:  1744-8344     ISO Abbreviation:  Expert Rev Cardiovasc Ther     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101182328     Medline TA:  Expert Rev Cardiovasc Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  1599-608     Citation Subset:  IM    
Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Current status of blood pressure management after stroke.
Next Document:  Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?